title: Reply to: "Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors".
authors.affiliation: Department of Medicine, Division of Infectious Disease, University of Connecticut Health Center, Farmington, Connecticut.
authors.forename: Lisa
authors.initials: L
authors.lastname: Chirch
authors.affiliation: Department of Medicine, Division of Infectious Disease, University of Connecticut Health Center, Farmington, Connecticut.
authors.forename: Kevin
authors.initials: K
authors.lastname: Dieckhaus
authors.affiliation: Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: grant@uchc.edu.
authors.forename: Jane M
authors.initials: JM
authors.lastname: Grant-Kels
mesh_terms: D001691:Biological Therapy / Q000009:adverse effects*; D003141:Communicable Diseases / Q000150:complications* / Q000175:diagnosis*; D006801:Humans; D012871:Skin Diseases / Q000150:complications* / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D014409:Tumor Necrosis Factor-alpha